Lotus Pharmaceutical Co Ltd (1795) — Cash Flow-to-Debt Ratio
Lotus Pharmaceutical Co Ltd (1795) has a Cash Flow-to-Debt Ratio of 0.02x as of December 2025, meaning its operating cash flow of NT$1.35 Billion could theoretically repay 0% of its total liabilities (NT$82.37 Billion) in one year. Explore 1795 long-term investments to assets to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Lotus Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio (2009–2025)
Historical debt coverage capacity for Lotus Pharmaceutical Co Ltd across 17 annual periods. Also explore Lotus Pharmaceutical Co Ltd asset portfolio for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Lotus Pharmaceutical Co Ltd (2009–2025)
Year-by-year debt coverage analysis for Lotus Pharmaceutical Co Ltd. For market capitalisation and broader financial context, see Lotus Pharmaceutical Co Ltd (1795) total market value.
| Year | CF-to-Debt Ratio | Operating CF (TWD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.09x | NT$7.48 Billion | NT$82.37 Billion | ▼ -72.1% |
| 2024 | 0.33x | NT$6.15 Billion | NT$18.92 Billion | ▲ +215.5% |
| 2023 | 0.10x | NT$1.61 Billion | NT$15.66 Billion | ▼ -56.6% |
| 2022 | 0.24x | NT$3.72 Billion | NT$15.66 Billion | ▲ +1915.5% |
| 2021 | 0.01x | NT$119.66 Million | NT$10.15 Billion | ▼ -93.3% |
| 2020 | 0.18x | NT$1.95 Billion | NT$11.01 Billion | ▲ +494.8% |
| 2019 | 0.03x | NT$302.81 Million | NT$10.17 Billion | ▼ -73.2% |
| 2018 | 0.11x | NT$796.98 Million | NT$7.17 Billion | ▲ +49.4% |
| 2017 | 0.07x | NT$592.29 Million | NT$7.96 Billion | ▼ -58.5% |
| 2016 | 0.18x | NT$1.23 Billion | NT$6.88 Billion | ▲ +12.6% |
| 2015 | 0.16x | NT$1.08 Billion | NT$6.77 Billion | ▲ +215.0% |
| 2014 | -0.14x | NT$-1.03 Billion | NT$7.46 Billion | ▲ +25.9% |
| 2013 | -0.19x | NT$-95.84 Million | NT$512.97 Million | ▼ -53.6% |
| 2012 | -0.12x | NT$-54.45 Million | NT$447.79 Million | ▲ +16.4% |
| 2011 | -0.15x | NT$-76.29 Million | NT$524.73 Million | ▼ -221.3% |
| 2010 | 0.12x | NT$59.19 Million | NT$493.75 Million | ▼ -66.5% |
| 2009 | 0.36x | NT$89.50 Million | NT$250.19 Million | — |